Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL28028781 | 1.00 | — | — | |
| Bicarbonate SCHEMBL8209384 | 0.93 | CA1 (0.83) | — | |
| Bicarbonate SCHEMBL7705691 | 0.93 | CA1 (0.83) | — | |
| Bicarbonate SCHEMBL294626 | 0.93 | CA1 (0.83) | — | |
| Bicarbonate SCHEMBL308226 | 0.93 | — | — | |
| Bicarbonate SCHEMBL5836395 | 0.93 | CA1 (0.83) | — | |
| Bicarbonate SCHEMBL10386542 | 0.93 | CA1 (0.83) | — | |
| Bicarbonate SCHEMBL8000370 | 0.93 | CA1 (0.83) | — | |
| Bicarbonate SCHEMBL21796220 | 0.93 | CA1 (0.83) | — | |
| Bicarbonate SCHEMBL10904150 | 0.93 | CA1 (0.83) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117276518-B | Tin-base alloy hard carbon composite material and preparation method thereof | 云南坤天新能源有限公司 | 2024-07-26 | — | — | CN | claimed |
| CN-117276518-A | Tin-base alloy hard carbon composite material and preparation method thereof | 云南坤天新能源有限公司 | 2023-12-22 | — | — | CN | claimed |
| CN-120057916-A | Method for preparing high-purity graphite by roasting waste graphite with sodium carbonate-sodium borate | 昆明理工大学 | 2025-05-30 | — | — | CN | disclosed |
| CN-117276518-B | Tin-base alloy hard carbon composite material and preparation method thereof | 云南坤天新能源有限公司 | 2024-07-26 | — | — | CN | disclosed |
| CN-118139645-A | Boronated amino acid compositions including BTS and BTS (OMe) for boron neutron capture therapy and methods thereof | TAE生命科学有限责任公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-117276518-A | Tin-base alloy hard carbon composite material and preparation method thereof | 云南坤天新能源有限公司 | 2023-12-22 | — | — | CN | disclosed |
| CN-109789146-B | Chemokine receptor modulators and uses thereof | 拉普特医疗公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-115947681-A | Modulators of integrated stress pathways | 卡里科生命科学有限责任公司 | 2023-04-11 | — | — | CN | disclosed |
| CN-115916226-A | Oncolytic viral compositions and methods for treating cancer | 希望之城 | 2023-04-04 | — | — | CN | disclosed |
| CN-115884980-A | Peptide platinum complexes and methods of use thereof | 奥康维路士有限责任公司 | 2023-03-31 | — | — | CN | disclosed |
| CN-112840031-B | High throughput cloning and use of paired bipartite immunoreceptor polynucleotides | 根路径基因组学公司 | 2023-03-24 | — | — | CN | disclosed |
| CN-110891942-A | Oxadiazole derivative, preparation method and medical application thereof | 四川科伦博泰生物医药股份有限公司 | 2020-03-17 | — | — | CN | disclosed |
| CN-110891596-A | Antibody variable domains and antibody constructs | 希望之城 | 2020-03-17 | — | — | CN | disclosed |
| CN-105658648-B | Deoxycytidine kinase inhibitors | 加利福尼亚大学董事会 | 2020-03-17 | — | — | CN | disclosed |
| CN-110891974-A | Mesothelin binding proteins | 哈普恩治疗公司 | 2020-03-17 | — | — | CN | disclosed |
| CN-106660991-B | Antiproliferative compounds and methods of use thereof | 细胞基因公司 | 2020-03-13 | — | — | CN | disclosed |
| CN-110801454-A | Use of Bruton's Tyrosine Kinase (BTK) inhibitors | 药品循环有限责任公司 | 2020-02-18 | — | — | CN | disclosed |
| CN-105899196-B | Formulations of (S) -3- (4- ((4- (morpholinylmethyl) benzyl) oxy) -1-oxoisoindolin-2-yl) piperidine-2, 6-dione | 细胞基因公司 | 2020-02-14 | — | — | CN | disclosed |
| CN-110730660-A | Nrf and HIF activators/HDAC inhibitors and methods of treatment using the same | 伊利诺伊大学评议会 | 2020-01-24 | — | — | CN | disclosed |
| CN-110545827-A | Viral methods of T cell therapy | INTIMA BIOSCIENCE INC | 2019-12-06 | — | — | CN | disclosed |